C4L Events

C4L events are dynamic gatherings that promote innovation and collaboration in the field of Life Sciences. Attendees can anticipate a lively atmosphere featuring engaging presentations and networking opportunities. These gatherings serve as a hub for thought leaders and experts to share their insights, while participants can gain valuable knowledge and build meaningful connections.

The C4L Innovators’ Forum comprises a series of inspirational events that serve as a meeting point for students, academia, and industry professionals. These events facilitate in-depth discussions and exploration of cutting-edge translational topics within various Life Sciences Engineering fields and beyond.

Given that many EPFL SV graduates pursue careers in industry, the primary objective of the Innovators’ Forum is to address subjects beneficial to students, PhD candidates, Postdocs, and emerging startups. The forum aims to provide valuable insights and guidance for successful career paths in industry or entrepreneurship.

The EPFL Life-sciences Start-up Social event goes beyond providing a platform for like-minded individuals to connect; C4L is also dedicated to identifying the common needs of MedTech and BioTech start-ups and uncovering ways for them to continue leveraging the advantages offered by the EPFL ecosystem

2nd EPFL Life-sciences Start-up Social

October 3, 2024 from 4 p.m. to 6 p.m. in SV 1717

Innovate4Life is pleased to invite you to the second EPFL Life-sciences Start-up Social on October 3rd, 2024, from 4 p.m. to 6 p.m. in SV 1717.

Besides creating a platform for meeting like-minded individuals under one roof, the goal of the event is to understand the common needs of MedTech and BioTech start-ups and how they can still benefit from the EPFL ecosystem. Last year was a great success with over 65 participants and active networking and conversation.

The outline of the event is as follows:

  • Welcome by Prof. Bart Deplancke, SV Vice-Dean of Innovation
  • Inspiring keynote lecture by Prof. Patrick Aebischer, Senior partner at ND capital and President Emeritus of EPFL
  • Pitch session by innovative start-ups launched at EPFL
  • Interactive discussion panel with local stakeholders including Dr. Ursula Oesterle, EPFL Vice-President of Innovation
  • Networking cocktail from 6 p.m. onwards

The event is free, but registration is mandatory.

Please register HERE


Transforming Drug Discovery using Digital Biology
by Daphne Koller, CEO and Founder of insitro

Modern medicine has given us effective tools to treat some of the most significant and burdensome diseases. At the same time, it is becoming consistently more challenging and more expensive to develop new therapeutics. A key factor in this trend is that we simply don’t understand the underlying biology of disease, and which interventions might meaningfully modulate clinical outcomes and in which patients. To achieve this goal, we are bringing together large amounts of high content data, taken both from humans and from human-derived cellular systems generated in our own lab. Those are then used to learn a meaningful representation of biological states via cutting edge machine learning methods, which enable us to make predictions about novel targets, coherent patient segments, and the clinical effect of molecules. Our ultimate goal is to develop a new approach to drug development that uses high-quality data and ML models to design novel, safe, and effective therapies that help more people, faster, and at a lower cost. 

About Daphne Koller
Daphne Koller is CEO and Founder of insitro, a machine learning-driven drug discovery and development company. Daphne is also co-founder of Engageli, was the Rajeev Motwani Professor of Computer Science at Stanford University, where she served on the faculty for 18 years, the co-CEO and President of Coursera, and the Chief Computing Officer of Calico Labs. She is the author of over 300 refereed publications with an h-index of 146. Daphne was recognized as one of TIME Magazine’s 100 most influential people in 2012. She received the MacArthur Foundation Fellowship in 2004, the ACM Prize in Computing in 2008, the ACM AAAI Allen Newell Award in 2019, and the AnitaB.org Technical Leadership Abie Award Winner in 2022. She was inducted into the National Academy of Engineering in 2011 and elected a fellow of the American Association for Artificial Intelligence in 2004, the American Academy of Arts and Sciences in 2014, and the International Society of Computational Biology in 2017.

EPFL Life-sciences Start-up Social

May 4, 2023 from 5 p.m. to 7 p.m. in SV 1717

Besides creating a ground for meeting like-minded people under one roof, the goal of the event is to understand the common needs of MedTech and BioTech start-ups and how they could still benefit from the EPFL ecosystem.

The outline of the event is as follows:

  • Welcome by Prof. Bart Deplancke, SV Vice-Dean of Innovation
  • Inspiring keynote lecture by Dr. André Mercanzini, Founder and CSO of Aleva Neurotherapeutics
  • Pitch session by innovative start-ups launched at EPFL
  • Interactive discussion panel with local stakeholders including Dr. Ursula Oesterle, EPFL Vice-President of Innovation
  • Networking cocktail

Hybrid Event: SV 1717 and Zoom

Lionel received his education in France and the United States and started his career in Canada as an engineer. He worked with technical professionals from all over the world and in Germany and Italy on expatriate assignments. The cultural adaptation process, after immigrating to Canada and working on international assignments for multinational companies, taught him so much that he decided to use the knowledge to help professionals from all over the world to achieve career success and organizations benefit from the opportunities brought by a diverse workforce and the global market.

Over the past fifteen years, Lionel has provided cross-cultural training, coaching and consulting services to over 20,000 people through a wide range of business, government, academic, professional and non-profit organizations in fourteen countries (Canada, the U.S., Bermuda, Mexico, Peru, Belgium, Switzerland, France, the UK, Turkey, UAE, Hong Kong, China and Korea).

Lionel is a thought provoking and educational speaker / facilitator who presented at over 200 conferences and venues across Canada and the United States. He is the author of two books examining the impact of cultural differences on business at the organizational and individual level entitled:

  • Managing Cultural Diversity in Technical Professions
  • Recruiting, Retaining and Promoting Culturally Diverse Employeess

Lionel holds a Ph.D. in Chemical Engineering from the California Institute of Technology, USA and a “Diplôme d’ingénieur polytechnicien” from the École Polytechnique de Paris, France.

Lionel Laroche, President at MultiCultural Business Solutions Inc.

Hybrid Event: SV 1717 and Zoom

Matt is a leading head hunter within the Swiss Pharmaceutical industry and has experience working with small start-ups and biotech’s to some of the big names like Moderna, Lonza and Novartis. In addition to this he runs a small YouTube channel and has over 12,000 followers on Linked-in. He’s passionate about helping people to understand how recruitment works and also is a big advocate for self improvement and personal development.

SPEAKER: Matt Beedle, Executive Partner at NonStop Consulting

Hybrid Event: SV 1717 and Zoom

An introduction about how to generate the supporting scientific evidence of innovative nutrition and the role and capabilities of R&D scientists in that domain.

A lively discussion about how bio-engineers and life science graduates fit in the NIHS, and about skills that are most important for jobs, internships.

SPEAKER: Eline M. van der Beek, PhD, Head of Nestlé Institute of Health Sciences (NIHS)

Via Zoom, 17:00 – 18:00

Discover Merck’s new approach to science and their research areas and discuss opportunities and ways of collaboration.

SPEAKER: Sven Pötzsch, Senior Innovation Manager at Merck Healthcare KGaA, Strategic Innovation (SI)

In his position as a Senior Innovation Manager at Merck Healthcare KGaA, Strategic Innovation (SI), Sven is responsible for the scouting, evaluating, and managing of strategic alliances with academic research institutions and other open innovation initiatives.

The main goal in these initiatives is to develop an inspiring and shared purpose that enables the Merck R&D teams to collaborate beyond internal borders and to expand our opportunities by collective innovation.

Prior to joining SI, Sven was a Lab Head and Scientific Manager at Central Analytics of Merck. In this role he was responsible for a broad quantitative bioanalytical support (LC-MS/MS) in a variety of Healthcare R&D and Life-Science related tasks like DMPK, Biomarker analytics and Metabolomics.

Sven is a chemist by training and holds a Ph.D. in Analytical Chemistry.

Via Zoom, 18:00 – 19:00

Explore the different careers and role types in the MedTech industry and discover how to effectively transition from your studies and academia to industry. In the highly interactive session, we will also approach the importance of Linkedn and other social media to find your dream job.

SPEAKER: Elena Kyria, Founder of Elemed, Europe’s leading MedTech technical recruiter

Elena Kyria is an award winning talent acquisition specialist, focused on professional branding and talent attraction in the EU medtech industry. Having worked with startups through to global corporations, Elena is well versed in the challenges associated with attracting and retaining talent. Elena began her career at the recruiting firm Huntress, where she was responsible for starting the medical device recruitment division. Today, she is the founder of Elemed, a boutique talent management agency uniquely positioned to help the Medtech industry reach candidates in the wake of the new regulations. Alongside Elemed, Elena is also a Linkedin all- star user and manages a thriving online community of over 6000 professionals. She also coaches and supports top talent on how to build a strong professional brand, to help maximise career possibilities. Elena is also passionate about supporting new talent entering the medtech industry, frequently giving talks to universities and associations such as the University of Cambridge and Medtech accelerator.


17:00 – 18:00

Setting Milestones in Medical Device Development
Ary Saaman, PhD, Regulatory Affairs Professional Society, Switzerland Chapter

18:00 – 19:00

Advances in Nanoimmunotherapies
Abraham J.P. Teunissen, PhD, Director of Radiochemistry, Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, United States